Patient experience sub-study of a randomised UK multicentre phase 2 trial of ASTX727 versus hydroxycarbamide/best supportive care in myelodysplastic (MDS)/myeloproliferative (MPN) overlap syndromes (AMMO)
Ward, A. Taylor, S. Punnett, G. Devaraj, R. Sankhalpara, C. Record, R. Batta, K. Byrne, J. Cargo, C. Chowdhury, O.
Ward, A.
Taylor, S.
Punnett, G.
Devaraj, R.
Sankhalpara, C.
Record, R.
Batta, K.
Byrne, J.
Cargo, C.
Chowdhury, O.
Abstract
Description
Date
2025
Publisher
Collections
Keywords
Type
Article
Citation
Ward A, Taylor S, Punnett G, Devaraj R, Sankhalpara C, Record R, et al. Patient experience sub-study of a randomised UK multicentre phase 2 trial of ASTX727 versus hydroxycarbamide/best supportive care in myelodysplastic (MDS)/myeloproliferative (MPN) overlap syndromes (AMMO). Blood. 2025 NOV 3;146:8164-5.